Physician profile
Jonathon Lindner
NPI 1992167712
$21,819.56
in general payments reported to CMS, 2019-2025
22 companies · $96.19 in 2025
The $96.19 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $193 · 2020: $386 · 2021: $8,272 · 2022: $11K · 2023: $359 · 2024: $1,648 · 2025: $96.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,253 · Food and Beverage: $850.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,252.91 |
| Food and Beverage | $850.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $18,878.67 | 2021-2025 | Journey II, Legion Revision, Ri Hip Navigation |
| Stryker Corporation | $1,179.71 | 2021-2022 | |
| Depuy Synthes Sales INC. | $900.43 | 2019-2024 | Attune, Actis |
| Acumed LLC | $130.25 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $97.22 | 2022 | |
| Kci USA, INC. | $94.50 | 2021 | |
| Alpha Orthopedic Systems | $72.97 | 2020 | |
| Medical Device Business Services, INC. | $70.39 | 2019 | |
| Zimmer Biomet Holdings, INC. | $64.78 | 2023-2024 | Genex, Genex, Gel-One Cross-Linked Hyaluronate |
| Si-Bone, INC. | $63.11 | 2020-2021 | |
| Ethicon US, LLC | $33.52 | 2020 | |
| Orthofix Medical, INC. | $32.36 | 2019-2020 | |
| Paragon 28, INC. | $26.86 | 2019-2020 | |
| Acell, INC. | $26.38 | 2019 | |
| Blue Surgical LLC | $24.27 | 2025 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $22.96 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $20.18 | 2025 | |
| Axogen | $19.68 | 2020 | |
| Heron Therapeutics, INC. | $16.34 | 2023 | Zynrelef |
| Vericel Corporation | $15.89 | 2023 | Maci |
| Pacira Therapeutics, INC. | $14.68 | 2019 | |
| Baudax Bio INC. | $14.41 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathon Lindner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.